Metal 3D printing for medical devices is continually on the rise as physicians, technologists, and researchers are increasingly taking advantage of the technology’s boundless flexibility. 3D printed metal implants especially in orthopedics and craniomaxillofacial (CMF) space are some of the earliest devices gaining FDA clearance and wider manufacturing adoption. Biocompatibility of metal/metal alloy, advancement in metallurgy, innate design freedom, and mass customization option offered by 3D printing suggest potential future better implants that could result in greater surgical success and clinical outcome. As the industry progresses, newer or improved manufacturing processes promise a new generation of healthcare applications.
In this conference, we are fortunate to hear from a diverse panel of experts who will share with us their latest research & development, industry insights, and entrepreneurial activities.
This event also serves to network freely and to connect Pitch3D start-ups and investors during the breakout session, you can apply here. The on-demand recording will also be available here after the event.
Check back soon for precise event timing!
Apply to speak or sponsor the event: email@example.com
Fabio Sant’Ana has Precision Mechanics degree and Business Administration Bachelor’s , born and raised in São Paulo he has 30 years experience in helping companies to aquire and take full advantage of 3d Machining and Additive Manufacturing Equipment . Entrepreneur and knowledge avid is member of stardarts organizations ASTM F42 Additive Manufacturing , ABNT CEE-261 Manufatura Aditiva e ABNT CB-26 Odonto-Médico-Hospitalar . CAD/CAM , Surface Modelling and EBM specialist he is passionate in connect people and companies to the right tools to accomplish the mission.
Tuan TranPham is the Chief Revenue Officer (CRO) at AZUL 3D, Inc, and prior to that he spend 19 years working for seven of the largest 3D printing companies, such as Z Corp, 3D Systems, Objet, Stratasys, Arcam (a GE company), Desktop Metal and AREVO.